|
|
 |
|
Total Number of Holdings (excluding cash): 50
| GE HealthCare Technologies Inc. |
GEHC |
36266G107 |
973 |
$74,502.61 |
2.26% |
| Cochlear Limited |
COH.AU |
Q25953102 |
714 |
$72,013.35 |
2.19% |
| West Pharmaceutical Services, Inc. |
WST |
955306105 |
175 |
$72,208.50 |
2.19% |
| Alcon Inc. |
ALC.SW |
H01301128 |
1,001 |
$71,479.47 |
2.17% |
| Teleflex Incorporated |
TFX |
879369106 |
511 |
$71,422.47 |
2.17% |
| Coloplast A/S (Class B) |
COLOB.DC |
K16018192 |
980 |
$70,702.56 |
2.15% |
| Insulet Corporation |
PODD |
45784P101 |
473 |
$70,798.64 |
2.15% |
| Koninklijke Philips N.V. |
PHIA.NA |
N7637U112 |
2,623 |
$70,699.41 |
2.15% |
| Smith & Nephew Plc |
SN/.LN |
G82343164 |
4,739 |
$69,992.14 |
2.13% |
| The Cooper Companies, Inc. |
COO |
216648501 |
1,176 |
$70,030.80 |
2.13% |
| Medtronic Plc |
MDT |
G5960L103 |
723 |
$69,798.42 |
2.12% |
| Siemens Healthineers AG |
SHL.GY |
D6T479107 |
1,460 |
$69,788.08 |
2.12% |
| Straumann Holding AG (Registered) |
STMN.SW |
H8300N127 |
592 |
$69,780.07 |
2.12% |
| BioMerieux |
BIM.FP |
F1149Y232 |
687 |
$69,333.99 |
2.11% |
| Edwards Lifesciences Corporation |
EW |
28176E108 |
751 |
$69,099.51 |
2.10% |
| Sonova Holding AG (Registered) |
SOON.SW |
H8024W106 |
201 |
$69,014.79 |
2.10% |
| Becton, Dickinson and Company |
BDX |
075887109 |
348 |
$68,862.24 |
2.09% |
| Mettler-Toledo International Inc. |
MTD |
592688105 |
41 |
$68,667.21 |
2.09% |
| Carl Zeiss Meditec AG (Bearer) |
AFX.GY |
D14895102 |
1,762 |
$68,585.28 |
2.08% |
| Demant A/S |
DEMANT.DC |
K3008M105 |
1,251 |
$68,344.91 |
2.08% |
| Abbott Laboratories |
ABT |
002824100 |
642 |
$68,180.40 |
2.07% |
| Waters Corporation |
WAT |
941848103 |
147 |
$68,019.84 |
2.07% |
| Steris Plc |
STE |
G8473T100 |
298 |
$67,681.76 |
2.06% |
| Zimmer Biomet Holdings, Inc. |
ZBH |
98956P102 |
718 |
$67,865.36 |
2.06% |
| Danaher Corporation |
DHR |
235851102 |
291 |
$67,578.93 |
2.05% |
| Stryker Corporation |
SYK |
863667101 |
231 |
$67,419.66 |
2.05% |
| Terumo Corporation |
4543.JP |
J83173104 |
4,460 |
$67,568.55 |
2.05% |
| Thermo Fisher Scientific Inc. |
TMO |
883556102 |
97 |
$67,609.00 |
2.05% |
| Align Technology, Inc. |
ALGN |
016255101 |
448 |
$67,150.72 |
2.04% |
| Globus Medical, Inc. (Class A) |
GMED |
379577208 |
857 |
$66,888.85 |
2.03% |
| Sartorius Stedim Biotech |
DIM.FP |
F8005V210 |
268 |
$66,695.05 |
2.03% |
| LivaNova Plc |
LIVN |
G5509L101 |
837 |
$66,097.89 |
2.01% |
| Sysmex Corporation |
6869.JP |
J7864H102 |
5,434 |
$66,180.00 |
2.01% |
| Agilent Technologies, Inc. |
A |
00846U101 |
375 |
$65,576.25 |
1.99% |
| Bio-Rad Laboratories, Inc. (Class A) |
BIO |
090572207 |
175 |
$65,131.50 |
1.98% |
| Intuitive Surgical, Inc. |
ISRG |
46120E602 |
151 |
$65,233.51 |
1.98% |
| Revvity, Inc. |
RVTY |
714046109 |
415 |
$65,155.00 |
1.98% |
| Hoya Corporation |
7741.JP |
J22848105 |
394 |
$64,834.75 |
1.97% |
| Fisher & Paykel Healthcare Corporation Limited |
FPH.NZ |
Q38992105 |
2,392 |
$64,129.83 |
1.95% |
| LeMaitre Vascular, Inc. |
LMAT |
525558201 |
793 |
$64,185.42 |
1.95% |
| Penumbra, Inc. |
PEN |
70975L107 |
200 |
$63,790.00 |
1.94% |
| ResMed Inc. |
RMD |
761152107 |
278 |
$63,923.32 |
1.94% |
| Merit Medical Systems, Inc. |
MMSI |
589889104 |
733 |
$63,213.92 |
1.92% |
| Boston Scientific Corporation |
BSX |
101137107 |
1,497 |
$62,844.06 |
1.91% |
| DexCom, Inc. |
DXCM |
252131107 |
760 |
$62,540.40 |
1.90% |
| Baxter International Inc. |
BAX |
071813109 |
2,627 |
$60,421.00 |
1.84% |
| WuXi AppTec Co., Ltd. (Class H) |
2359.HK |
Y971B1118 |
2,377 |
$56,043.88 |
1.70% |
| Olympus Corporation |
7733.JP |
J61240107 |
5,040 |
$55,212.70 |
1.68% |
| Shanghai Microport Medbot (Group) Co., Ltd. (Class H) |
2252.HK |
Y768JD106 |
16,500 |
$44,553.38 |
1.35% |
| US Dollar |
$USD |
|
24,433 |
$24,433.37 |
0.74% |
| Japanese Yen |
$JPY |
|
42,336 |
$268.65 |
0.01% |
| Euro |
$EUR |
|
0 |
$0.06 |
0.00% |
| Pound Sterling |
$GBP |
|
0 |
$0.15 |
0.00% |
| TPG Inc. (CVR) |
2602335D |
436CVR021 |
612 |
$0.00 |
0.00% |
Holdings are subject to change.
The holdings information set forth above for the date indicated reflects creation and redemption transactions from the prior business day and may differ from the holdings information currently available from the Fund's custodian and accounting agent. With respect to the market value of the Fund's holdings set forth above, the pricing sources are generally third party vendors. The Fund ultimately relies on pricing information provided by the Fund's accounting agent.
|
|
The information presented is not intended to constitute an investment recommendation for, or advice to, any specific person. By providing this information, First Trust is not undertaking to give advice in any fiduciary capacity within the meaning of ERISA, the Internal Revenue Code or any other regulatory framework. Financial professionals are responsible for evaluating investment risks independently and for exercising independent judgment in determining whether investments are appropriate for their clients.
|